Fortress Biotech
FBIO
82 hedge funds and large institutions have $81.1M invested in Fortress Biotech in 2021 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 28 increasing their positions, 23 reducing their positions, and 11 closing their positions.
36% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 11
22% more repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 23
4% more funds holding
Funds holding: 79 → 82 (+3)
6% more call options, than puts
Call options by funds: $688K | Put options by funds: $647K
0.17% more ownership
Funds ownership: 2% → 2.16% (+0.17%)
17% less capital invested
Capital invested by funds: $97.5M → $81.1M (-$16.4M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
+$2.81M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$1.31M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$878K |
| 4 |
Wells Fargo
San Francisco,
California
|
+$505K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$469K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Advisers
New York
|
-$711K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$603K |
| 3 |
Prudential Financial
Newark,
New Jersey
|
-$366K |
| 4 |
Two Sigma Investments
New York
|
-$287K |
| 5 |
Morgan Stanley
New York
|
-$207K |
FBIO Hedge Fund Activity: Q4 2021 in Review
82 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q4 2021, worth a combined $81.1M — down 17% from $97.5M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new FBIO positions and 11 closed out — a net gain of 4 holders — while 28 added to existing stakes and 23 trimmed.
The largest buyer was Nantahala Capital Management, adding an estimated $2.81M. The largest seller was Two Sigma Advisers, cutting an estimated $711K.
- 82 institutional investors held Fortress Biotech (FBIO) as of Q4 2021, up from 79 in Q3 2021.
- Funds reported $81.1M of Fortress Biotech stock for Q4 2021, down 17% quarter-over-quarter.
- 15 funds opened new Fortress Biotech positions in Q4 2021 and 11 closed out, a net change of +4 holders.
- The largest Fortress Biotech buyer in Q4 2021 was Nantahala Capital Management, an estimated $2.81M added.
- The largest Fortress Biotech seller in Q4 2021 was Two Sigma Advisers, an estimated $711K sold.
Based on aggregated 13F filings for Q4 2021.